Steve E. Krognes Guardant Health, Inc. (GH) insider trading activity

GH Quotes by TradingView

Steve E. Krognes is Director of Guardant Health, Inc.. Currently has a direct ownership of 10,682 shares of GH, which is worth approximately $480,369. The most recent transaction as insider was on Mar 31, 2025, when has been sold 154 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K
4.52% 3M change
229.79% 12M change
Total Value Held $480,369

Steve E. Krognes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2025
BUY
Exercise of conversion of derivative security
-
154 Added 1.42%
10,682 Common Stock
Feb 28 2025
BUY
Exercise of conversion of derivative security
-
154 Added 1.44%
10,528 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
154 Added 1.46%
10,374 Common Stock
Dec 31 2024
BUY
Exercise of conversion of derivative security
-
155 Added 1.49%
10,220 Common Stock
Nov 30 2024
BUY
Exercise of conversion of derivative security
-
154 Added 1.51%
10,065 Common Stock
Oct 31 2024
BUY
Exercise of conversion of derivative security
-
154 Added 1.53%
9,911 Common Stock
Sep 30 2024
BUY
Exercise of conversion of derivative security
-
154 Added 1.55%
9,757 Common Stock
Aug 31 2024
BUY
Exercise of conversion of derivative security
-
155 Added 1.59%
9,603 Common Stock
Jul 31 2024
BUY
Exercise of conversion of derivative security
-
154 Added 1.6%
9,448 Common Stock
Jun 30 2024
BUY
Exercise of conversion of derivative security
-
154 Added 1.63%
9,294 Common Stock
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
5,592 Added 37.96%
9,140 Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
-
155 Added 4.19%
3,548 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
-
154 Added 4.34%
3,393 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
154 Added 4.54%
3,239 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
-
154 Added 4.75%
3,085 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
155 Added 5.02%
2,931 Common Stock
Dec 31 2023
BUY
Exercise of conversion of derivative security
-
154 Added 5.26%
2,776 Common Stock
Nov 30 2023
BUY
Exercise of conversion of derivative security
-
154 Added 5.55%
2,622 Common Stock
Oct 31 2023
BUY
Exercise of conversion of derivative security
-
154 Added 5.87%
2,468 Common Stock
Sep 30 2023
BUY
Exercise of conversion of derivative security
-
155 Added 6.28%
2,314 Common Stock
Aug 31 2023
BUY
Exercise of conversion of derivative security
-
154 Added 6.66%
2,159 Common Stock
Jul 31 2023
BUY
Exercise of conversion of derivative security
-
154 Added 7.13%
2,005 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
-
1,851 Added 50.0%
1,851 Common Stock

Also insider at

DNLI
Denali Therapeutics Inc. Healthcare
Director
GRTS
Gritstone bio, Inc. Healthcare
Director
PLRX
PLIANT THERAPEUTICS, INC. Healthcare
Director
SEK

Steve E. Krognes

Director
South San Francisco, CA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GH